JPRN-UMIN000003586已完成2 期
A Phase II Study of Adjuvant Carboplatin and Weekly Paclitaxel in Patients with Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer - A Phase II Study of Adjuvant Carboplatin and Weekly Paclitaxel in Patients with Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) active interstitial pneumonitis determined by chest CT 2) active infection or gastric ulcer 3) drug allergy against polyoxethylated castor oil 4) active concomitant malignancy 5) severe complications (i.e. heart diseases required treatment, myocardial infarction within 6 months, liver cirrhosis) 6) pregnant or lactating women 7) severe drug allergy 8) other conditions not suitable for this study
研究者
相似试验
已完成
不适用
A phase II study of concurrent weekly carboplatin and paclitaxel combined with definitive radiotherapy for advanced-stage cervical cancer.terine cervical cancerJPRN-UMIN000017232Osaka University Hospital80
招募中
2 期
Phase II study of Carboplatin and alternate-day administrations of TS-1 in patients with advanced squamous cell lung cancer.Squamous cell carcinoma of the lungJPRN-UMIN000009308Kyoto Thoracic Oncology Research Group35
未知
2 期
Phase II study in combination with Carboplatin and TS-1 for Cancer of unknown primaryCancer of unknown primaryJPRN-UMIN000001236ational Cancer Center Hospital, Tokyo35
已完成
不适用
A Phase II Study of biweekly Carboplatin, nab-paclitaxel, and concurrent Thoracic radiation therapy for Patients with local advanced Non-small cell Lung CancerJPRN-UMIN000023802Hirosaki University28
已完成
2 期
Phase II study of Carboplatin plus weekly nab-paclitaxel in elderly patients with non-small cell lung cancer using MNASquamous cell lung cancerJPRN-UMIN000012051OSAKA-LCSG30